News

News

18 February 2018

The CHUS Fleurimont Considered a Reference for the Treatment of Lung Cancer

Centre de recherche du CHUS logo

The Centre hospitalier universitaire de Sherbrooke, the CHUSS du CIUSSS de l’Estrie-CHUS, was designated as the reference centre for treating lung cancer. It is also in the process of becoming a reference for the treatment of esophageal cancer.

For its part, the CISSS de la Montérégie-Centre/Hôpital Charles-Lemoyne was recognized as an affiliated centre for treating these types of cancer.

The reference centre (Sherbrooke) and its affiliated centre will therefore collaborate to develop their expertise and provide state-of-the-art care to their patients. This also means patients will be treated in either of these two centres.

Source : La Tribune

Back to the news

Leave a Reply

Your email address will not be published. Required fields are marked *

Filter
Twitter
Sherbrooke Innopole’s mandate ends on March 31, 2024. We invite you to contact Entreprendre Sherbrooke or the Service du développement économique of the Ville de Sherbrooke for further services.
Thank you to all Sherbrooke industrial and technological businesses, as well as to all our partners for the trust granted since 2009!